When the fundamentals of master data management are handled properly in an end-to-end solution from a trusted partner like IMS Health, a company benefits from: • Improved data quality: With a ...

Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...

DANBURY, Conn.–(BUSINESS WIRE)–IMS Health (NYSE:IMS) has acquired Privacy Analytics Incorporated, a leader in technology solutions for de-identifying and ...

DANBURY, Conn. & REDWOOD SHORES, Calif.--(BUSINESS WIRE)--IMS Health (NYSE:IMS), the global provider of healthcare information and technology solutions, and Reltio, the enterprise data-driven ...

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) has acquired Privacy Analytics Incorporated, a leader in technology solutions for de-identifying and ...

Cloud-Based Applications, Embedded Analytics and Integrated Systems Focused on Lowering Pharma and Payer Costs, Improving Patient Outcomes PARSIPPANY, NJ, March 12, 2014 – Life sciences companies are ...

IMS Health’s IPO raised more than $1.3 billion Friday by selling 65 million shares for $20 apiece. Shares quickly rose to $23 during Friday’s trading. Like Castlight Health, whose $3 billion public ...

IMS Health filed for an initial public offering last week, which may raise as much as $1 billion for the healthcare data and consulting firm. IMS Health was acquired in 2010 by private equity firms ...

IMS Health today announced the acquisition of 360 Vantage, a leading provider of cloud-based multi-channel CRM and closed loop marketing technologies, to further extend its commercial ...

NEW YORK, April 18 (Reuters) - IMS Health , which provides market data on pharmaceuticals sales, on Wednesday reported first-quarter profit fell 27 percent from a year ago, when it had tax benefits, ...

(Reuters) - Global spending on medicines will reach $1.4 trillion in 2020, driven by increased healthcare access in emerging markets and high-priced new drugs for cancer and other diseases, according ...